CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
118 hedge funds and large institutions have $755M invested in Cymabay Therapeutics in 2018 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
10% more funds holding
Funds holding: 107 → 118 (+11)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Holders
118
Holding in Top 10
5
Calls
$640K
Puts
$491K
Top Buyers
| 1 | +$38.7M | |
| 2 | +$27.7M | |
| 3 | +$19.4M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$17.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$14.6M |
Top Sellers
| 1 | -$42.5M | |
| 2 | -$13.4M | |
| 3 | -$8.31M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$7.14M |
| 5 |
Goldman Sachs
New York
|
-$5.13M |